Current Edition

Serialisation: The Great Challenge for the Pharmaceutical Industry – Considerations on China

Most of the big pharma players have been working during the past years to implement projects linked to serialisation, despite the uncertainty regarding concrete rules, data and specific regulations. Marga Romo of Nekicessa discusses China: the next deadline for serialisation in China is 2015, with the well-known 128C code, different from the expected data matrix that is likely to be implemented in Europe; and this code is becoming a nightmare for the serialisation-responsible people in the companies, due to technical problems related to length and grading.….pdf